Acute Physiologic and Chronic Health Examination II and Sequential Organ Failure Assessment Scores for Predicting Outcomes of Out-of-Hospital Cardiac Arrest Patients Treated with Therapeutic Hypothermia

Sung Joon Kim; Yong-Su Lim; Jin Seong Cho; Jin Joo Kim; Won Bin Park; Hyuk Jun Yang

doi:10.4266/kjccm.2014.29.4.288

Articles

Page Path: HOME > Acute Crit Care > Volume 29(4); 2014 > Article

Original Article Acute Physiologic and Chronic Health Examination II and Sequential Organ Failure Assessment Scores for Predicting Outcomes of Out-of-Hospital Cardiac Arrest Patients Treated with Therapeutic Hypothermia: Sung Joon Kim, Yong-Su Lim, M.D., Jin Seong Cho, M.D., Jin Joo Kim, M.D., Won Bin Park, M.D., Hyuk Jun Yang, M.D.; The Korean Journal of Critical Care Medicine 2014;29(4):288-296.
DOI: https://doi.org/10.4266/kjccm.2014.29.4.288
Published online: November 30, 2014

Department of Emergency Medicine, Gachon University Gil Medical Center, Incheon, Korea

Correspondence to: Yong-Su Lim, Department of Emergency Medicine, Gachon University Gil Medical Center, 774-21 Namdongdae-ro, Namdong-gu, Incheon 405-760, Korea. Tel: +82-32-460-3015, Fax: +82-32-460-3019, E-mail: yongem@gilhospital.com

• Received: July 31, 2014 • Revised: September 16, 2014 • Accepted: September 17, 2014

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

6,605 Views
46 Download
1 Crossref

prev next

Full Article

Download PDF

Abstract
Introduction
Materials and Methods
Results
Discussion
NOTES
References

Abstract

Background
The aim of this study was to assess the relationship between acute physiologic and chronic health examination (APACHE) II and sequential organ failure assessment (SOFA) scores and outcomes of post-cardiac arrest patients treated with therapeutic hypothermia (TH).
Methods
Out-of-hospital cardiac arrest (OHCA) survivors treated with TH between January 2010 and December 2012 were retrospectively evaluated. We captured all components of the APACHE II and SOFA scores over the first 48 hours after intensive care unit (ICU) admission (0 h). The primary outcome measure was in-hospital mortality and the secondary outcome measure was neurologic outcomes at the time of hospital discharge. Receiver-operating characteristic and logistic regression analysis were used to determine the predictability of outcomes with serial APACHE II and SOFA scores.
Results
A total of 138 patients were enrolled in this study. The area under the curve (AUC) for APACHE II scores at 0 h for predicting in-hospital mortality and poor neurologic outcomes (cerebral performance category: 3–5) was more than 0.7, and for SOFA scores from 0 h to 48 h the AUC was less than 0.7. Odds ratios used to determine associations between APACHE II scores from 0 h to 48 h and in-hospital mortality were 1.12 (95% confidence interval [CI], 1.03–1.23), 1.13 (95% CI, 1.04–1.23), and 1.18 (95% CI, 1.07–1.30).
Conclusions
APACHE II, but not SOFA score, at the time of ICU admission is a modest predictor of in-hospital mortality and poor neurologic outcomes at the time of hospital discharge for patients who have undergone TH after return of spontaneous circulation following OHCA.
Keywords: acute physiologic and chronic health examination; cardiopulmonary resuscitation; hypothermia, induced; organ dysfunction scores; outcome assessment; out-of-hospital cardiac arrest

Introduction

The number of out-of-hospital cardiac arrests (OHCA) in Korea was estimated to be 97,291 between 2006 and 2010. The age-standardized incidence of OHCA increased from 37.5 cases to 46.8 cases per 100,000 persons in 2010, and survival to hospital discharge was 3.0% in 2010.[1] Still, survivors of cardiac arrest with return of spontaneous circulation (ROSC) after cardiopulmonary resuscitation (CPR) often die due to refractory shock or recurrent cardiac arrest (CA), or experience devastating neurological impairment as a result of ischemia/reperfusion-induced cerebral injury.[2,3] Therapeutic hypothermia (TH) has been shown to alleviate anoxic brain injury and improve neurologic outcomes in patients after ROSC.[4,5]

The prediction of neurological outcomes is a crucial factor in determining treatment strategies for CA patients with ROSC. Severity assessments help to reduce ineffective life-sustaining treatment and promote efficient distribution of health care resources.[6,7] When the risk of death is accurately predicted, patients and their families can prepare for an expected death and physicians can more effectively stratify patients based on adjusted predictive risks for their quality evaluation or research.[8] In previous studies, the survival of CA patients varied according to the location at which CA occurred, the presence or absence of a bystander who could perform CPR, access to a professional rescuer who could perform CPR, initial cardiac rhythm, and no-flow and low-flow times.[9,10] However, prediction tools such as the acute physiologic and chronic health examination (APACHE),[11] Simplified acute physiologic score (SAPS),[12] and sequential organ failure assessment (SOFA)[13] do not incorporate certain variables that may affect outcomes of CA patients because these scoring systems were developed for application to patients with critical illness. It is therefore necessary to verify the utility of these scoring systems for quantifying the severity of illness in CA patients.

This study aimed to assess the utility of APACHE II and SOFA scores in predicting outcomes of CA patients who underwent TH after ROSC.

Materials and Methods

1) Subjects

This study was conducted at a 1,300-bed university hospital with 100 intensive care unit (ICU) beds and nearly 90,000 emergency-room visits each year. Among adult patients who presented to the emergency room due to OHCA over the course of 36 months from January 1, 2010 to December 31, 2012, those who underwent TH after CPR and ROSC were screened, and their medical records were retrospectively analyzed. Patients with traumatic CA were excluded along with those who died before ICU admission and those with insufficient patient information.

2) Therapeutic hypothermia

An identical protocol was followed for the treatment of OHCA patients with ROSC during the study period. The target temperature of 33°C was achieved by either surface or endovascular cooling in addition to a palliative method with 4°C normal saline infusion, ice packs, and bladder irrigation. Surface cooling was performed using either a water blanket (Blanketrol^® II Cincinnati Sub-Zero Products, OH, USA) or a pad (ArcticGel^TM Pads & Arctic Sun^® 2000, Medivance, CO, USA). Endovascular cooling was performed using a catheter (Cool Line^® Catheter & CoolGard 3000^®, ZOLL, MA, USA). Patient temperature was monitored with a rectal thermometer to ensure that the target temperature was achieved and maintained for 24 hours. After the initiation of cooling, rewarming began at a rate of 0.2–0.3°C every hour in order to increase body temperature to 36.5°C, and increased temperature was maintained for 72 hours. All patients required endotracheal intubation and mechanical ventilation before TH, and they were given sedatives, analgesics and muscle relaxants during TH.

3) Methods

All patients who presented with OHCA and underwent TH were enrolled in the cardiac arrest registry. From the registry, patients’ demographic variables including age, gender, past medical history, in-hospital mortality, neurologic outcomes at the time of discharge, and other variables associated with APACHE II and SOFA scores were analyzed. The APACHE II and SOFA scores were calculated at the time of admission (0 hour), at 24 hours, and at 48 hours based on abnormal vital signs and lab results. The Glasgow coma scale, which is included in the APACHE II and SOFA scores, represents the last value measured before sedation.[14] There were patients who received post cardiac arrest care (PACC) in the emergency room because there were no beds available in the ICU. In those cases, the time of initiation of PACC was considered to be the time of admission. Data related to CA were retrospectively collected according to the Utstein style: the time of CA occurrence, location of CA, witness status, bystander CPR, initial cardiac rhythm, medication used during CA, CPR, and time of ROSC.[15,16] The primary endpoint was in-hospital mortality and the secondary endpoint was neurologic outcomes at the time of hospital discharge. Neurologic status at the time of discharge was measured using a 5-point cerebral performance category (CPC): a CPC of 1 indicates a good cerebral performance with the ability to lead a normal life and/or mild neurologic symptoms; a CPC of 2 indicates sufficient neurologic function for independent activities of daily living; a CPC of 3 indicates consciousness, moderate cerebral disability, and inability to perform independent activities of daily living; a CPC of 4 indicates comatose or persistent vegetative state; and a CPC of 5 indicates death.[17] A CPC of 1–2 is considered a good neurologic outcome, and a CPC of 3–5 is considered a poor neurologic outcome.[4,5] The time from CA to ROSC is defined as the downtime, which is further divided into no-flow time (the time from CA to initiation of CPR) and low-flow time (the time from CPR to ROSC).[8]

4) Statistical analysis

Statistical analysis was performed using SPSS, version 18 (IBM, NY, USA) and MedCalc, version 12.7.7.0 (MedCalc Software, Ostend, Belgium). A p value less than 0.05 was considered to be statistically significant. Continuous variables were presented as mean values and standard deviations (SD) or median values and interquartile ranges (IQR) depending on distribution, and categorical variables were presented as relative frequencies (%). Either independent t-tests or Mann-Whitney U tests were used to compare differences between groups when the dependent variable was continuous. A chi-square test was used to examine the association between categorical variables. A logistic regression analysis was used in multivariate analysis of variables associated with in-hospital mortality and neurologic outcomes at the time of discharge by building a model with variables that had a p value of 0.2 or less on univariate analysis and those reported as significant in previous studies through backward stepwise elimination. To assess the discrimination power of each CPC score, the area under the receiver operating characteristic curve (ROC) was calculated (AUC) using in-hospital mortality and neurologic outcomes as independent variables. An AUC value > 0.9 indicates high discrimination power, an AUC value between 0.7 and 0.9 indicates moderate discrimination power, and an AUC value < 0.7 indicates low discrimination power.[18] To verify the utility of APACHE II and SOFA scores as predictors of in-hospital mortality and poor neurologic outcomes at the time of discharge, cutoff values were calculated using ROC curves, AUC values, and Youden’s index of the scores at each time point. The corresponding sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were also calculated with 95% CIs. To reduce false positive results, the cut-off value that allows 100% specificity was determined at each time point. Model calibration was assessed by the Hosmer-Lemeshow goodness of fit test. p values > 0.05 were considered to be calibrated.

Results

1) Subject characteristics and cardiac arrest data

A total of 138 CA patients participated in this study. Subject characteristics and cardiac arrest data are summarized in Table 1. There were 95 men (68.6%), and the mean age of all subjects was 52.9 years (SD ± 15.4). In-hospital mortality occurred in 54 patients (41.3%), and good neurologic outcomes were observed in 47 patients (34.1%) (42 with CPC 1, 5 with CPC 2, 5 with CPC 3, 29 patients with CPC 4 and 57 patients with CPC 5). Among patients who died in the hospital, 9 (15.7%) died within 48 hours. The median downtime was 30 min (IQR 23–42), and the mean lactate level was 8.4 mmol/L (SD: ± 3.4). The median time from ROSC to ICU admission was 145 min (IQR 88–227).

2) Variables associated with in-hospital mortality and neurologic outcomes

In-hospital mortality was affected by initial cardiac rhythm, cardiogenic CA, vasopressor administration within 48 hours, and baseline lactate level (Table 2). Neurologic outcomes at the time of discharge were associated with gender, history of coronary artery disease, witnessed CA, initial cardiac rhythm, cardiogenic CA, duration of CA, no-flow time, and baseline lactate level (Table 3). APACHE II and SOFA scores at all time points were related to mortality whereas APACHE II scores at 0 hour and 48 hours were related to neurologic outcomes at the time of discharge (Table 4).

3) Receiver-operating characteristic curve analysis for APACHE II and SOFA scores

Time-dependent AUC values of APACHE II and SOFA scores in predicting in-hospital mortality and poor neurologic outcomes are presented in Table 5. The predictability of APACHE II scores was assessed at each time point using ROC curves as shown in Fig. 1. and 2. The AUC for APACHE II scores at 0 hour were 0.7 and 0.73, respectively, showing a moderate discriminatory power, whereas AUC values decreased to less than 0.7 at 24 and 48 hours. The AUC for SOFA scores was also low at less than 0.7 at all time points, showing a low discriminatory power. Hosmer-Lemeshow statistics were adequate for the scoring system since most p-values exceeded 0.05, although APACHE II scores associated with in-hospital mortality showed p values of 0.045 and 0.042 at 24 and 48 hours, respectively. The odds ratios (OR) with 95% CI for APACHE II scores in predicting in-hospital mortality at 0 hour, 24 hours, and 48 hours were 1.12 (1.03–1.23), 1.13 (1.04–1.23) and 1.18 (1.07–1.30), respectively. The OR of APACHE II scores for predicting neurologic outcomes at the time of discharge at the same time points were 1.15 (1.05–1.25), 1.14 (1.05–1.24) and 1.18 (1.08–1.29), respectively. The OR for SOFA scores in predicting in-hospital mortality at 48 hours was 1.33 (1.12–1.58), and the OR for SOFA scores in predicting neurologic outcomes at 0 hour, 24 hours, and 48 hours were 1.15 (1.01–1.32), 1.17 (1.01–1.35), and 1.33 (1.12–1.58), respectively. The cutoff value for baseline APACHE II scores in predicting in-hospital mortality was 21, with a sensitivity of 80.7%, specificity of 53.1%, PPV of 54.8% and NPV of 79.6%. The cutoff value for baseline APACHE II scores in predicting poor neurologic outcomes was 20, with a sensitivity of 82.4%, specificity of 59.6%, PPV of 79.8% and NPV of 63.6%. The cut-off values that corresponded to 100% specificity for baseline APACHE II scores in predicting in-hospital mortality and neurologic outcomes were 32 and 29, respectively.

Discussion

The purpose of this study was to assess the time-dependent predictive performance of APACHE II and SOFA scores in predicting in-hospital mortality and neurologic outcomes at the time of discharge in OHCA patients who underwent TH after CPR with ROSC. As a result, APACHE II scores were moderate predictors of the two outcomes with AUC values of 0.7 and 0.73 respectively, indicating moderate discriminatory power. The overall model calibration was also supported by Hosmer-Lemeshow statistics (p value > 0.05)

Adrie et al.[9] identified initial cardiac rhythm, no-flow and low-flow times, serum lactate level, and creatinine level as being independently associated with poor neurologic outcomes at the time of discharge among OHCA patients. In this study, the same variables with the exception of creatinine played a similar role. According to a meta-analysis by Sasson et al.[10] rates of survival to hospital discharge were high among CA patients with witnessed CA, presence of emergency medical system (EMS), bystander CPR, CA caused by ventricular fibrillation or ventricular tachycardia, and ROSC at the site of initial collapse. In this study, initial cardiac rhythm was also identified as a variable associated with in-hospital mortality, though this was not statistically significant, likely due to low rates of witnessed CA, performance of CPR by bystanders,[1] and disparities in EMS presence.

The APACHE II scoring system was developed by Knaus et al.[11] in 1985 to classify the severity of illness. This scoring system was used for 5,815 patients in ICUs at 13 hospitals, and was found to correlate with in-hospital mortality. APACHE II scores have been effectively used to predict outcomes in patients with critical illness including sepsis,[19] pesticide poisoning,[20] and trauma,[21] and also in surgical patients.[22] In 2012, Donnino et al.[8] used APACHE II scores as a prognostic predictor in CA patients. In their study, 80 patients (35%) underwent TH among 228 patients who had CA outside or inside of a hospital. Also, the ORs of APACHE II scores for predicting in-hospital mortality at 0 hour, 24 hours, 48 hours, and 72 hours were 1.09 (1.05–1.13), 1.10 (1.06–1.15), 1.20 (1.12–1.28) and 1.22 (1.13–1.31), respectively. The ORs for APACHE II scores for predicting neurologic outcomes at the time of discharge at the same time points were 1.08 (1.03–1.12), 1.10 (1.06–1.15), 1.18 (1.11–1.25), and 1.21 (1.23–1.29), respectively. These findings were similar to those of our study, in that APACHE II scores had moderate discriminatory power in predicting in-hospital mortality and poor neurologic outcomes at 24 hours, 48 hours, and 72 hours. As previously mentioned, this study demonstrated that APACHE II scores at 0 hour had a better discriminatory power for outcome prediction than those at other time points. Thus, the results of these studies are inconsistent. These differences may be due to the fact that this study included only OHCA patients and scores were measured at the time of ICU admission instead of after ROSC. Also, TH can be accompanied by hypotension, bradycardia, increases in oxygen consumption and carbon dioxide production, hypothermia, electrolyte imbalance, and decreases in platelet and white blood cell counts.[23] The 24 hours following ICU admission is referred to as the maintenance phase in this study, meaning that APACHE II scores may elevate during this period, leading to low discriminatory power.

The SOFA score was proposed by Vincent et al.[13] in 1993 as a scoring system to assess the extent of organ dysfunction. It is an excellent tool for assessing the incidence of organ dysfunction/failure and predicting morbidity. In a study by Firreira et al.[24] conducted in ICU patients at a Belgian hospital in 2001, the mean and maximum SOFA scores which were measured over 96 hours were valid outcome predictors. SOFA scores have been reported to be reliable predictors of mortality and morbidity in several studies. Roberts et al.[25] used SOFA scores to determine the extent of multiple organ dysfunction in 208 CA patients after ROSC. Of those, 170 (84%) were in hospital cardiac arrest (IHCA) patients, and 77 of them (38%) underwent TH. To measure the extent of organ dysfunction/failure, serial SOFA scores were obtained at 24 hours intervals over 72 hours, and multivariate logistic regression was used to determine the association between SOFA scores and in-hospital mortality, with adjustments for cerebral dysfunction. According to the results of their study, organ dysfunction was the most common post-cardiac arrest sequelae, followed by cerebral injury, and respiratory or cardiovascular dysfunction. Their multivariate analysis also showed that the maximum baseline extracerebral SOFA score was associated with in-hospital mortality (OR 2.37 [95% CI, 1.28–4.38]). Also, the total maximum baseline extracerebral SOFA score was independently related to in-hospital mortality over 72 hours (OR 1.95 [95% CI, 1.15–3.29]). In particular, the total maximum SOFA scores for respiratory or cardiovascular disorders were independently associated with in-hospital mortality, reflecting hemodynamic instability and oxygenation failure. This study however demonstrated that SOFA scores had an OR of 1.33 (95% CI, 1.12–1.58) at 48 hours as a predictive value for in-hospital mortality. These results differed from those of Roberts et al.[25] which may be because our study calculated baseline SOFA scores at the time of ICU admission, and their association with in-hospital mortality and neurologic outcomes was assessed using the ROC curve and AUC values.

In addition to APACHE II and SOFA scores, the SAPS score is sometimes used to assess severity of illness. SAPS II, which was introduced by Le Gall et al.[12] is the most common version used in the clinical setting. Salciccioli et al.[26] compared the SAPS II and SAPS III in predicting outcomes in 274 OHCA/IHCA patients. Of those, 103 (38%) underwent TH. In their study, SAPS II was calculated based on the worst score for each variable during the first 24 hours after ROSC, whereas SAPS III was calculated based on variables at the time of ICU admission. AUC values for SAPS II in predicting in-hospital mortality and poor neurologic outcomes at the time of discharge were 0.7 and 0.71, respectively, showing moderate discrimination, while AUC values for SAPS III were 0.66 and 0.65. A recent study by Bisbal et al.[27] also found a higher performance of SAPS II in predicting mortality in CA patients when comparing the two scoring systems.

In 2006, Adrie et al.[9] proposed use of the OHCA score to assess severity of illness in OHCA patients using initial cardiac rhythm, no-flow and low-flow times, serum lactate level, and creatinine level. They reported an AUC value of 0.82 for the OHCA score, which was calculated for predicting poor neurologic outcomes. Hunziker et al.[28] also supported the utility of OHCA scores with an AUC value of 0.85 in their study conducted to verify the utility of OCHA scores. The OHCA score is easy to calculate and utilize because it uses variables predicted at the time of ICU admission, with no observation period necessary. However, it is difficult to estimate the no-flow and low-flow times accurately, making scoring calculations more complicated.

This study has several limitations. First, it was conducted at a single hospital, and a sample size calculation was not performed. In addition, scoring was performed within the first 48 hours after ICU admission according to our TH protocol, since the effects of hypothermia including rewarming would not resolve and medications such as sedatives and muscle relaxants would not metabolize with 48 hours. Given the trends in AUC values, higher discrimination could be achieved if APACHE and SOFA score calculation extended to 72 hours after ICU admission.

In conclusion, APACHE II scores at the time of ICU admission showed moderate discriminatory power in predicting in-hospital mortality and poor neurologic outcomes at the time of discharge in OHCA patients who underwent TH after CPR with ROSC. However, SOFA scores showed a low discriminatory power. Additionally, patients with APACHE II scores of 32 or higher had a high risk of in-hospital death. Therefore, this score may be useful in predicting in-hospital mortality in OHCA patients receiving TH. Further large scale studies are needed to explore the utility of various scoring systems as predictors of mortality and neurologic outcomes in OHCA patients receiving TH.

NOTES

No potential conflict of interest relevant to this article was reported.

Fig. 1.

Comparison of receiver operating characteristic curves for serial APACHE II scores to predict in-hospital mortality using the area under the curve. The white dots on each curved line indicate the cutoff values at serial time points. APACHE: acute physiologic and chronic health examination; AUC: area under the curve; CV: cutoff values.

Fig. 2.

Comparison of receiver operating characteristic curves for serial APACHE II scores to predict neurologic outcomes at the time of hospital discharge using the area under the curve. The white dots on each curved line indicates the cutoff values at serial time points. CPC: cerebral performance category; APACHE: acute physiologic and chronic health examination; AUC: area under the curve; CV: cutoff values.

Table 1.

Baseline characteristics of the study population (N = 138)

Characteristic	All subjects
Age, yr (± SD)	52.9 (15.4)
Male sex, n (%)	95 (68.8)
Co-morbid conditions, n (%)
Hypertension	43 (31.2)
Diabetes	25 (18.1)
Heart failure	11 (8.0)
Coronary artery disease	20 (14.5)
Cerebrovascular disease	8 (5.8)
COPD/asthma	12 (8.7)
Chronic kidney disease	6 (4.3)
Arrest location, home, n (%)	66 (47.8)
Witnessed arrest, n (%)	103 (74.6)
Bystander CPR, n (%)	56 (40.6)
Initial arrest rhythm, n (%)
Asystole/PEA	89 (64.5)
VF/VT	49 (35.5)
Cause of arrest, cardiac, n (%)	86 (62.3)
Downtime, min (IQR)	30 (23–42)
No-flow time, min (IQR)	6 (0–10)
Low-flow time, min (IQR)	22 (16–36)
Epinephrine administered during CPR, mg (IQR)	2 (2–5)
Number of vasopressors within 48 h (IQR)	1 (1–1)
Initial lactate, mmol/L (± SD)	8.4 (3.4)
Survival to discharge, n (%)	81 (58.7)
Good CPC at hospital discharge, n (%)	47 (34.1)

SD: standard deviation; COPD: chronic obstructive pulmonary disease; CPR: cardiopulmonary resuscitation; PEA: pulseless electrical activity; VF: ventricular fibrillation; VT: ventricular tachycardia; IQR: interquartile range; CPC: cerebral performance category (good CPC: 1–2, poor CPC: 3–5).

Table 2.

Comparison of variables between patients that died versus those that were alive at the time of hospital discharge (N = 138)

	In-hospital mortality

	Survived (n = 81)	Died (n = 57)	p value
Age, yr (± SD)	51.5 (15.3)	55.0 (15.6)	0.192
Male sex, n (%)	60 (74.1)	35 (61.4)	0.114
Co-morbid conditions, n (%)
Hypertension	25 (30.9)	18 (31.6)	0.929
Diabetes	11 (13.6)	14 (24.6)	0.099
Heart failure	4 (4.9)	7 (12.3)	0.200
Coronary artery disease	15 (18.5)	5 (8.8)	0.109
Cerebrovascular disease	4 (4.9)	4 (7.0)	0.717
COPD/asthma	4 (4.9)	8 (14.0)	0.073
Chronic kidney disease	2 (2.5)	4 (7.0)	0.230
Arrest location, home, n (%)	39 (48.1)	27 (47.4)	0.928
Witnessed arrest, n (%)	63 (77.8)	40 (70.2)	0.312
Bystander CPR, n (%)	35 (43.2)	21 (36.8)	0.453
Initial arrest rhythm, n (%)			< 0.001
Asystole/PEA	42 (51.9)	47 (82.5)
VF/VT	39 (48.1)	10 (17.5)
Cause of arrest, cardiac, n (%)	60 (74.1)	26 (45.6)	0.001
Downtime, min (IQR)	30 (21–42)	31 (24–44)	0.224
No-flow time, min (IQR)	6 (0–10)	6 (0–11)	0.421
Low-flow time, min (IQR)	23 (14–35)	22 (17–37)	0.407
Epinephrine administered during CPR, mg (IQR)	3 (1–6)	2 (2–4)	0.675
Number of vasopressors within 48 h (IQR)	2 (1–3)	2 (2–4)	0.020
Initial lactate, mmol/L (± SD)	7.9 (3.5)	9.1 (3.3)	0.047

Table 3.

Comparisons of variables in patients with good versus poor neurologic outcomes at the time of hospital discharge (N = 138)

	Neurologic outcome at hospital discharge

	Good^a (n = 47)	Poor^b (n = 91)	p value
Age, yr (± SD)	49.7 (13.1)	54.6 (16.3)	0.063
Male sex, n (%)	41 (87.2)	54 (59.3)	0.001
Co-morbid conditions, n (%)
Hypertension	16 (34.0)	27 (29.7)	0.599
Diabetes	6 (12.8)	19 (20.9)	0.241
Heart failure	2 (4.3)	9 (9.9)	0.332
Coronary artery disease	12 (25.5)	8 (8.8)	0.008
Cerebrovascular disease	1 (2.1)	7 (7.7)	0.265
COPD/asthma	2 (4.3)	10 (11.0)	0.221
Chronic kidney disease	1 (2.1)	5 (5.5)	0.664
Arrest location, home, n (%)	21 (44.7)	45 (49.5)	0.595
Witnessed arrest, n (%)	43 (91.5)	60 (65.9)	0.001
Bystander CPR, n (%)	20 (42.6)	36 (39.6)	0.734
Initial arrest rhythm, n (%)			< 0.001
Asystole/PEA	14 (29.8)	75 (82.4)
VF/VT	33 (70.2)	16 (17.6)
Cause of arrest, cardiac, n (%)	46 (97.9)	40 (44.0)	< 0.001
Down time, min (IQR)	25 (18–39)	35 (24–46)	0.004
No-flow time, min (IQR)	5 (0–7)	6 (0–12)	0.028
Low-flow time, min (IQR)	20 (10–33)	23 (18–38)	0.060
Epinephrine administered during CPR, mg (IQR)	3 (1–6)	2 (2–4)	0.702
Number of vasopressors within 48 h (IQR)	2 (1–3)	2 (1–3)	0.573
Initial lactate, mmol/L (± SD)	7.0 (3.2)	9.1 (3.3)	0.001

^a Good means cerebral performance category (CPC) scores ranging from 1 to 2 (CPC 1: n = 42, CPC 2: n = 5).

^b Poor means CPC scores ranging from 3 to 5 (CPC 3: n = 5, CPC 4: n = 29, CPC 5: n = 57). SD: standard deviation; COPD: chronic obstructive pulmonary disease; CPR: cardiopulmonary resuscitation; PEA: pulseless electrical activity; VF: ventricular fibrillation; VT: ventricular tachycardia; IQR: interquartile range.

Table 4.

Serial APACHE II and SOFA scores according to mortality and neurologic outcomes (N = 138)

	In-hospital mortality			Neurologic outcome at hospital discharge

	Survived (n = 81)	Died (n = 57)	p value	Good^a (n = 47)	Poor^b (n = 91)	p value
APACHE II, 0 h (± SD)	21 (4)	24 (4)	< 0.001	19 (4)	24 (4)	< 0.001
APACHE II, 24 h (± SD)	27 (4)	30 (6)	0.002	27 (4)	29 (5)	0.074
APACHE II, 48 h (± SD)	23 (3)	27 (6)	< 0.001	23 (3)	26 (5)	< 0.001
SOFA, 0 h (± SD)	8 (2)	9 (2)	0.044	8 (2)	9 (2)	0.054
SOFA, 24 h (± SD)	9 (2)	10 (3)	0.040	9 (2)	10 (2)	0.420
SOFA, 48 h (± SD)	9 (2)	10 (3)	0.006	9 (2)	10 (2)	0.069

^a Good —means cerebral performance category (CPC) scores ranging from 1 to 2 (CPC 1: n = 42, CPC 2: n = 5).

^b Poor means CPC scores ranging from 3 to 5 (CPC 3: n = 5, CPC 4: n = 29, CPC 5: n = 57). APACHE: acute physiologic and chronic health examination; SOFA: sequential organ failure assessment; SD: standard deviation.

Table 5.

Performance of APACHE II and SOFA scores in predicting mortality and neurologic outcomes

	0 h	24 h	48 h
Number	138	135	129
APACHE II (± SD)	22 (5)	28 (5)	25 (5)
In-hospital mortality
OR (95% CI)	1.12 (1.03–1.23)	1.13 (1.04–1.23)	1.18 (1.07–1.30)
AUC (95% CI)	0.70 (0.61–0.78)	0.63 (0.54–0.73)	0.69 (0.61–0.77)
Poor neurologic outcome
OR (95% CI)	1.15 (1.05–1.25)	1.14 (1.05–1.24)	1.18 (1.08–1.29)
AUC (95% CI)	0.73 (0.64–0.82)	0.57 (0.47–0.67)	0.65 (0.56–0.74)
SOFA (± SD)	8 (2)	10 (2)	9 (2)
In-hospital mortality
OR (95% CI)	1.08 (0.93–1.25)	1.10 (0.97–1.24)	1.33 (1.12–1.58)
AUC (95% CI)	0.59 (0.50–0.69)	0.59 (0.50–0.69)	0.64 (0.54–0.74)
Poor neurologic outcome
OR (95% CI)	1.15 (1.01–1.32)	1.17 (1.01–1.35)	1.33 (1.12–1.58)
AUC (95% CI)	0.59 (0.49–0.69)	0.54 (0.44–0.64)	0.57 (0.47–0.67)

APACHE: acute physiologic and chronic health examination; SOFA: sequential organ failure assessment; SD: standard deviation; OR: odds ratio; CI: confidence interval; AUC: area under the curve of the receiver operator characteristic curve.

References

1). Ro YS, Shin SD, Song KJ, Lee EJ, Kim JY, Ahn KO, et al. A trend in epidemiology and outcomes of out-of-hospital cardiac arrest by urbanization level: a nationwide observational study from 2006 to 2010 in South Korea. Resuscitation 2013;84:547-57.Article PubMed
2). Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med 2004;30:2126-8.Article PubMed
3). Giberson TA, Bivens S, Cocchi M, Giberson B, Salciccoli J, Donnino M. The etiology of postarrest mortality stratified by location of arrest. Circulation 2011;124:A184.
4). Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346:549-56.Article PubMed
5). Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346:557-63.Article PubMed
6). Peberdy MA, Callaway CW, Neumar RW, Geocadin RG, Zimmerman JL, Donnino M, et al. Part 9: post-cardiac arrest care: 2010 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2010;122:S768-86.Article PubMed
7). Püttgen HA, Geocadin R. Predicting neurological outcome following cardiac arrest. J Neurol Sci 2007;261:108-17.Article PubMed
8). Donnino MW, Salciccioli JD, Dejam A, Giberson T, Giberson B, Cristia C, et al. APACHE II scoring to predict outcome in post-cardiac arrest. Resuscitation 2013;84:651-6.Article PubMed PMC
9). Adrie C, Cariou A, Mourvillier B, Laurent I, Dabbane H, Hantala F, et al. Predicting survival with good neurological recovery at hospital admission after successful resuscitation of out-of-hospital cardiac arrest: the OHCA score. Eur Heart J 2006;27:2840-5.Article PubMed
10). Sasson C, Rogers MA, Dahl J, Kellermann AL. Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 2010;3:63-81.Article PubMed
11). Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.Article PubMed
12). Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-63.Article PubMed
13). Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med 1996;22:707-10.Article PubMed
14). Livingston BM, Mackenzie SJ, MacKirdy FN, Howie JC. Should the pre-sedation glasgow coma scale value be used when calculating acute physiology and chronic health evaluation scores for sedated patients? Scottish intensive care society audit group. Crit Care Med 2000;28:389-94.Article PubMed
15). Cummins RO, Chamberlain DA, Abramson NS, Allen M, Baskett PJ, Becker L, et al. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein style. A statement for health professionals from a task force of the American heart association, the European resuscitation council, the heart and stroke foundation of Canada, and the Australian resuscitation council. Circulation 1991;84:960-75.Article PubMed
16). Jacobs I, Nadkarni V, Bahr J, Berg RA, Billi JE, Bossaert L, et al. Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries. A statement for healthcare professionals from a task force of the international liaison committee on resuscitation (American heart association, European resuscitation council, Australian resuscitation council, New Zealand resuscitation council, heart and stroke foundation of Canada, InterAmerican heart foundation, resuscitation council of Southern Africa). Circulation 2004;63:233-49.Article
17). Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480-4.Article PubMed
18). Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 2007;96:644-7.Article PubMed
19). Bohnen JM, Mustard RA, Oxholm SE, Schouten BD. APACHE II score and abdominal sepsis. A prospective study. Arch Surg 1988;123:225-9.Article PubMed
20). Kim YH, Yeo JH, Kang MJ, Lee JH, Cho KW, Hwang S, et al. Performance assessment of the SOFA, APACHE II scoring system, and SAPS II in intensive care unit organophosphate poisoned patients. J Korean Med Sci 2013;28:1822-6.Article PubMed PMC
21). Hwang SY, Lee JH, Lee YH, Hong CK, Sung AJ, Choi YC. Comparison of the sequential organ failure assessment, acute physiology and chronic health evaluation II scoring system, and trauma and injury severity score method for predicting the outcomes of intensive care unit trauma patients. Am J Emerg Med 2012;30:749-53.Article PubMed
22). Lee HN, Choi EY, Kim YH. Validation of APACHE II score and comparison of the performance of APACHE II and adjusted APACHE II models in a surgical intensive care unit. Korean J Crit Care Med 2011;26:232-7.Article
23). Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 2009;37:186-202.Article
24). Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001;286:1754-8.Article PubMed
25). Roberts BW, Kilgannon JH, Chansky ME, Mittal N, Wooden J, Parrillo JE, et al. Multiple organ dysfunction after return of spontaneous circulation in postcardiac arrest syndrome. Crit Care Med 2013;41:1492-501.Article PubMed
26). Salciccioli JD, Cristia C, Chase M, Giberson T, Graver A, Gautam S, et al. Performance of SAPS II and SAPS III scores in post-cardiac arrest. Minerva Anestesiol 2012;78:1341-7.PubMed PMC
27). Bisbal M, Jouve E, Papazian L, de Bourmont S, Perrin G, Eon B, et al. Effectiveness of SAPS III to predict hospital mortality for post-cardiac arrest patients. Resuscitation 2014;85:939-44.Article PubMed
28). Hunziker S, Bivens MJ, Cocchi MN, Miller J, Salciccioli J, Howell MD, et al. International validation of the out-of-hospital cardiac arrest score in the United States. Crit Care Med 2011;39:1670-4.Article PubMed

Figure & Data

References

Citations

Citations to this article as recorded by

Multiorgan failure in patients after out of hospital resuscitation: a retrospective single center study
Yaacov Hasin, Yigal Helviz, Sharon Einav
Internal and Emergency Medicine.2024; 19(1): 159. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Acute Physiologic and Chronic Health Examination II and Sequential Organ Failure Assessment Scores for Predicting Outcomes of Out-of-Hospital Cardiac Arrest Patients Treated with Therapeutic Hypothermia

Korean J Crit Care Med. 2014;29(4):288-296. Published online November 30, 2014

DOI: https://doi.org/10.4266/kjccm.2014.29.4.288

XML Download

Figure

Related articles

Ability of a modified Sequential Organ Failure Assessment score to predict mortality among sepsis patients in a resource-limited setting

Fig. 1. Comparison of receiver operating characteristic curves for serial APACHE II scores to predict in-hospital mortality using the area under the curve. The white dots on each curved line indicate the cutoff values at serial time points. APACHE: acute physiologic and chronic health examination; AUC: area under the curve; CV: cutoff values.

Fig. 2. Comparison of receiver operating characteristic curves for serial APACHE II scores to predict neurologic outcomes at the time of hospital discharge using the area under the curve. The white dots on each curved line indicates the cutoff values at serial time points. CPC: cerebral performance category; APACHE: acute physiologic and chronic health examination; AUC: area under the curve; CV: cutoff values.

Fig. 1.

Fig. 2.

Characteristic	All subjects
Age, yr (± SD)	52.9 (15.4)
Male sex, n (%)	95 (68.8)
Co-morbid conditions, n (%)
Hypertension	43 (31.2)
Diabetes	25 (18.1)
Heart failure	11 (8.0)
Coronary artery disease	20 (14.5)
Cerebrovascular disease	8 (5.8)
COPD/asthma	12 (8.7)
Chronic kidney disease	6 (4.3)
Arrest location, home, n (%)	66 (47.8)
Witnessed arrest, n (%)	103 (74.6)
Bystander CPR, n (%)	56 (40.6)
Initial arrest rhythm, n (%)
Asystole/PEA	89 (64.5)
VF/VT	49 (35.5)
Cause of arrest, cardiac, n (%)	86 (62.3)
Downtime, min (IQR)	30 (23–42)
No-flow time, min (IQR)	6 (0–10)
Low-flow time, min (IQR)	22 (16–36)
Epinephrine administered during CPR, mg (IQR)	2 (2–5)
Number of vasopressors within 48 h (IQR)	1 (1–1)
Initial lactate, mmol/L (± SD)	8.4 (3.4)
Survival to discharge, n (%)	81 (58.7)
Good CPC at hospital discharge, n (%)	47 (34.1)

	In-hospital mortality

	Survived (n = 81)	Died (n = 57)	p value
Age, yr (± SD)	51.5 (15.3)	55.0 (15.6)	0.192
Male sex, n (%)	60 (74.1)	35 (61.4)	0.114
Co-morbid conditions, n (%)
Hypertension	25 (30.9)	18 (31.6)	0.929
Diabetes	11 (13.6)	14 (24.6)	0.099
Heart failure	4 (4.9)	7 (12.3)	0.200
Coronary artery disease	15 (18.5)	5 (8.8)	0.109
Cerebrovascular disease	4 (4.9)	4 (7.0)	0.717
COPD/asthma	4 (4.9)	8 (14.0)	0.073
Chronic kidney disease	2 (2.5)	4 (7.0)	0.230
Arrest location, home, n (%)	39 (48.1)	27 (47.4)	0.928
Witnessed arrest, n (%)	63 (77.8)	40 (70.2)	0.312
Bystander CPR, n (%)	35 (43.2)	21 (36.8)	0.453
Initial arrest rhythm, n (%)			< 0.001
Asystole/PEA	42 (51.9)	47 (82.5)
VF/VT	39 (48.1)	10 (17.5)
Cause of arrest, cardiac, n (%)	60 (74.1)	26 (45.6)	0.001
Downtime, min (IQR)	30 (21–42)	31 (24–44)	0.224
No-flow time, min (IQR)	6 (0–10)	6 (0–11)	0.421
Low-flow time, min (IQR)	23 (14–35)	22 (17–37)	0.407
Epinephrine administered during CPR, mg (IQR)	3 (1–6)	2 (2–4)	0.675
Number of vasopressors within 48 h (IQR)	2 (1–3)	2 (2–4)	0.020
Initial lactate, mmol/L (± SD)	7.9 (3.5)	9.1 (3.3)	0.047

	Neurologic outcome at hospital discharge

	Good^a (n = 47)	Poor^b (n = 91)	p value
Age, yr (± SD)	49.7 (13.1)	54.6 (16.3)	0.063
Male sex, n (%)	41 (87.2)	54 (59.3)	0.001
Co-morbid conditions, n (%)
Hypertension	16 (34.0)	27 (29.7)	0.599
Diabetes	6 (12.8)	19 (20.9)	0.241
Heart failure	2 (4.3)	9 (9.9)	0.332
Coronary artery disease	12 (25.5)	8 (8.8)	0.008
Cerebrovascular disease	1 (2.1)	7 (7.7)	0.265
COPD/asthma	2 (4.3)	10 (11.0)	0.221
Chronic kidney disease	1 (2.1)	5 (5.5)	0.664
Arrest location, home, n (%)	21 (44.7)	45 (49.5)	0.595
Witnessed arrest, n (%)	43 (91.5)	60 (65.9)	0.001
Bystander CPR, n (%)	20 (42.6)	36 (39.6)	0.734
Initial arrest rhythm, n (%)			< 0.001
Asystole/PEA	14 (29.8)	75 (82.4)
VF/VT	33 (70.2)	16 (17.6)
Cause of arrest, cardiac, n (%)	46 (97.9)	40 (44.0)	< 0.001
Down time, min (IQR)	25 (18–39)	35 (24–46)	0.004
No-flow time, min (IQR)	5 (0–7)	6 (0–12)	0.028
Low-flow time, min (IQR)	20 (10–33)	23 (18–38)	0.060
Epinephrine administered during CPR, mg (IQR)	3 (1–6)	2 (2–4)	0.702
Number of vasopressors within 48 h (IQR)	2 (1–3)	2 (1–3)	0.573
Initial lactate, mmol/L (± SD)	7.0 (3.2)	9.1 (3.3)	0.001

	In-hospital mortality			Neurologic outcome at hospital discharge

	Survived (n = 81)	Died (n = 57)	p value	Good^a (n = 47)	Poor^b (n = 91)	p value
APACHE II, 0 h (± SD)	21 (4)	24 (4)	< 0.001	19 (4)	24 (4)	< 0.001
APACHE II, 24 h (± SD)	27 (4)	30 (6)	0.002	27 (4)	29 (5)	0.074
APACHE II, 48 h (± SD)	23 (3)	27 (6)	< 0.001	23 (3)	26 (5)	< 0.001
SOFA, 0 h (± SD)	8 (2)	9 (2)	0.044	8 (2)	9 (2)	0.054
SOFA, 24 h (± SD)	9 (2)	10 (3)	0.040	9 (2)	10 (2)	0.420
SOFA, 48 h (± SD)	9 (2)	10 (3)	0.006	9 (2)	10 (2)	0.069

	0 h	24 h	48 h
Number	138	135	129
APACHE II (± SD)	22 (5)	28 (5)	25 (5)
In-hospital mortality
OR (95% CI)	1.12 (1.03–1.23)	1.13 (1.04–1.23)	1.18 (1.07–1.30)
AUC (95% CI)	0.70 (0.61–0.78)	0.63 (0.54–0.73)	0.69 (0.61–0.77)
Poor neurologic outcome
OR (95% CI)	1.15 (1.05–1.25)	1.14 (1.05–1.24)	1.18 (1.08–1.29)
AUC (95% CI)	0.73 (0.64–0.82)	0.57 (0.47–0.67)	0.65 (0.56–0.74)
SOFA (± SD)	8 (2)	10 (2)	9 (2)
In-hospital mortality
OR (95% CI)	1.08 (0.93–1.25)	1.10 (0.97–1.24)	1.33 (1.12–1.58)
AUC (95% CI)	0.59 (0.50–0.69)	0.59 (0.50–0.69)	0.64 (0.54–0.74)
Poor neurologic outcome
OR (95% CI)	1.15 (1.01–1.32)	1.17 (1.01–1.35)	1.33 (1.12–1.58)
AUC (95% CI)	0.59 (0.49–0.69)	0.54 (0.44–0.64)	0.57 (0.47–0.67)

Table 1. Baseline characteristics of the study population (N = 138)

Table 2. Comparison of variables between patients that died versus those that were alive at the time of hospital discharge (N = 138)

Table 3. Comparisons of variables in patients with good versus poor neurologic outcomes at the time of hospital discharge (N = 138)

Good means cerebral performance category (CPC) scores ranging from 1 to 2 (CPC 1: n = 42, CPC 2: n = 5).

Poor means CPC scores ranging from 3 to 5 (CPC 3: n = 5, CPC 4: n = 29, CPC 5: n = 57). SD: standard deviation; COPD: chronic obstructive pulmonary disease; CPR: cardiopulmonary resuscitation; PEA: pulseless electrical activity; VF: ventricular fibrillation; VT: ventricular tachycardia; IQR: interquartile range.

Table 4. Serial APACHE II and SOFA scores according to mortality and neurologic outcomes (N = 138)

Good —means cerebral performance category (CPC) scores ranging from 1 to 2 (CPC 1: n = 42, CPC 2: n = 5).

Poor means CPC scores ranging from 3 to 5 (CPC 3: n = 5, CPC 4: n = 29, CPC 5: n = 57). APACHE: acute physiologic and chronic health examination; SOFA: sequential organ failure assessment; SD: standard deviation.

Table 5. Performance of APACHE II and SOFA scores in predicting mortality and neurologic outcomes